Efficacy of single dose intranasal dexmedetomidine for conscious sedation in dental practice in dentophobic uncooperative patients with intellectual disability.

Trial Profile

Efficacy of single dose intranasal dexmedetomidine for conscious sedation in dental practice in dentophobic uncooperative patients with intellectual disability.

Recruiting
Phase of Trial: Phase II

Latest Information Update: 20 Dec 2016

At a glance

  • Drugs Dexmedetomidine (Primary)
  • Indications Sedation
  • Focus Therapeutic Use
  • Acronyms KUKIDEX-2
  • Most Recent Events

    • 20 Dec 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top